Hyundai Pharmaceutical Co., Ltd. (004310) Ratios

― Followers

Hyundai Pharmaceutical Co., Ltd. Ratios

KR:004310's free cash flow for Q2 2026 was ₩0.24. For the 2026 fiscal year, KR:004310's free cash flow was decreased by ₩ and operating cash flow was ₩0.02. See a summary of the company’s cash flow.

Ratios	TTM	Nov 25	Nov 24	Nov 23	Nov 22
Liquidity Ratios
Current Ratio	1.69	1.13	1.36	1.31	1.26
Quick Ratio	1.10	0.68	0.86	0.90	0.96
Cash Ratio	0.12	0.04	0.18	0.25	0.38
Solvency Ratio	0.09	0.08	0.04	0.13	0.03
Operating Cash Flow Ratio	0.05	>-0.01	-0.04	-0.07	0.14
Short-Term Operating Cash Flow Coverage	0.14	>-0.01	-0.07	-0.12	0.40
Net Current Asset Value	₩ 11.80B	₩ -3.97B	₩ 2.24B	₩ 15.51B	₩ 7.04B
Leverage Ratios
Debt-to-Assets Ratio	0.22	0.30	0.31	0.25	0.22
Debt-to-Equity Ratio	0.39	0.61	0.61	0.46	0.46
Debt-to-Capital Ratio	0.28	0.38	0.38	0.32	0.31
Long-Term Debt-to-Capital Ratio	0.17	0.06	0.16	<0.01	0.10
Financial Leverage Ratio	1.75	2.03	1.98	1.83	2.09
Debt Service Coverage Ratio	0.42	0.17	0.15	0.28	0.14
Interest Coverage Ratio	3.30	1.75	0.09	3.63	6.87
Debt to Market Cap	0.25	0.52	0.52	0.36	0.29
Interest Debt Per Share	1.67K	1.99K	1.95K	1.52K	1.46K
Net Debt to EBITDA	3.69	6.28	9.59	1.74	0.91
Profitability Margins
Gross Profit Margin	35.83%	40.79%	41.75%	41.62%	42.31%
EBIT Margin	3.32%	1.72%	0.14%	5.48%	4.15%
EBITDA Margin	5.65%	3.95%	2.24%	7.31%	6.17%
Operating Profit Margin	3.00%	1.72%	0.10%	3.83%	4.90%
Pretax Profit Margin	2.63%	1.20%	-0.99%	4.44%	3.48%
Net Profit Margin	2.20%	1.31%	-0.33%	3.39%	-0.10%
Continuous Operations Profit Margin	2.20%	1.31%	-0.33%	3.39%	-0.10%
Net Income Per EBT	83.67%	109.08%	33.17%	76.20%	-2.90%
EBT Per EBIT	87.54%	69.92%	-958.06%	115.99%	71.14%
Return on Assets (ROA)	1.98%	1.51%	-0.37%	3.96%	-0.09%
Return on Equity (ROE)	4.19%	3.06%	-0.73%	7.23%	-0.19%
Return on Capital Employed (ROCE)	3.78%	3.45%	0.19%	7.76%	7.93%
Return on Invested Capital (ROIC)	2.68%	2.36%	0.05%	4.13%	-0.18%
Return on Tangible Assets	2.06%	1.58%	-0.38%	4.11%	-0.10%
Earnings Yield	1.72%	2.63%	-0.63%	5.72%	-0.12%
Efficiency Ratios
Receivables Turnover	4.02	4.29	4.55	4.64	3.83
Payables Turnover	7.96	8.36	10.12	8.92	5.19
Inventory Turnover	3.45	3.48	3.52	3.91	3.90
Fixed Asset Turnover	5.06	4.89	4.69	6.14	5.69
Asset Turnover	0.90	1.15	1.12	1.17	0.90
Working Capital Turnover Ratio	6.12	12.66	8.57	8.80	5.42
Cash Conversion Cycle	150.88	146.09	147.93	131.15	118.61
Days of Sales Outstanding	90.86	84.98	80.28	78.70	95.26
Days of Inventory Outstanding	105.89	104.77	103.70	93.38	93.64
Days of Payables Outstanding	45.88	43.66	36.05	40.93	70.28
Operating Cycle	196.75	189.75	183.98	172.08	188.90
Cash Flow Ratios
Operating Cash Flow Per Share	103.96	-4.72	-92.51	-167.66	417.94
Free Cash Flow Per Share	-9.46	-180.89	-528.44	-392.83	181.21
CapEx Per Share	113.42	176.17	435.93	225.17	236.73
Free Cash Flow to Operating Cash Flow	-0.09	38.35	5.71	2.34	0.43
Dividend Paid and CapEx Coverage Ratio	0.72	-0.02	-0.20	-0.66	1.57
Capital Expenditure Coverage Ratio	0.92	-0.03	-0.21	-0.74	1.77
Operating Cash Flow Coverage Ratio	0.06	>-0.01	-0.05	-0.12	0.29
Operating Cash Flow to Sales Ratio	0.02	>-0.01	-0.01	-0.03	0.07
Free Cash Flow Yield	-0.15%	-4.94%	-14.82%	-9.95%	3.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	51.22	38.07	-159.09	17.49	-818.73
Price-to-Sales (P/S) Ratio	0.97	0.50	0.52	0.59	0.83
Price-to-Book (P/B) Ratio	2.01	1.17	1.16	1.26	1.56
Price-to-Free Cash Flow (P/FCF) Ratio	-668.75	-20.26	-6.75	-10.06	26.74
Price-to-Operating Cash Flow Ratio	80.22	-776.97	-38.54	-23.56	11.59
Price-to-Earnings Growth (PEG) Ratio	0.05	-0.07	1.45	>-0.01	8.64
Price-to-Fair Value	2.01	1.17	1.16	1.26	1.56
Enterprise Value Multiple	20.78	18.91	32.80	9.85	14.33
Enterprise Value	237.79B	143.35B	129.26B	130.09B	143.93B
EV to EBITDA	20.78	18.91	32.80	9.85	14.33
EV to Sales	1.18	0.75	0.74	0.72	0.88
EV to Free Cash Flow	-813.12	-30.32	-9.53	-12.21	28.56
EV to Operating Cash Flow	73.98	-1.16K	-54.47	-28.62	12.38
Tangible Book Value Per Share	3.85K	2.86K	2.82K	2.92K	2.49K
Shareholders’ Equity Per Share	4.14K	3.14K	3.08K	3.12K	3.11K
Tax and Other Ratios
Effective Tax Rate	0.19	-0.09	0.67	0.24	1.03
Revenue Per Share	6.54K	7.34K	6.85K	6.67K	5.85K
Net Income Per Share	143.75	96.28	-22.41	225.81	-5.92
Tax Burden	0.84	1.09	0.33	0.76	-0.03
Interest Burden	0.79	0.70	-6.83	0.81	0.84
Research & Development to Revenue	0.08	0.09	0.09	0.07	0.05
SG&A to Revenue	0.18	0.16	0.18	0.17	0.17
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	0.72	-0.05	4.13	-0.74	-70.63

Currency in KRW